NOVOBIND

NovoBind's NBXs are the future in targeting and neutralizing pathogens safely in a specific, sustainable, and economical manner... We are committed to promoting workplace diversity, equity, and inclusion. We strive to grow our team with passionate individuals seeking to make a lasting impact... Working to combat rising resistance to anti-infectives and their accumulating residue in the environment, NovoBind develops next-generation biologics that target and neutralize the specific bacteria, viruses, and parasites that cause intestinal ailments in livestock, aquaculture, and pets. Our novel biotherapeutic solutions (NBXs) are based on single-domain antibodies and complementary to conventional treatments.

Primary location: Vancouver Canada